Pekao Towarzystwo Funduszy Inwestycyjnych S.A.

Position in GILD — Gilead Sciences, Inc.

CIK 2104543 WARSAW, R9

Back to GILD Full portfolio

Position in GILD

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$349,330

New position

Shares Held

2,765

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

0.22%

of 13F equity value

Holder Rank

#1,570

of 2,266 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Pekao Towarzystwo Funduszy Inwestycyjnych S.A. holds $5,016,109 across 6 Drug Manufacturers - General names. GILD ranks #6 (7.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	5,873	$1,477,881
2	AZN	Astrazeneca PLC	6,063	$1,149,666
3	AMGN	Amgen Inc	2,500	$905,300
4	JNJ	Johnson & Johnson	2,995	$760,640
5	MRK	Merck & Co., Inc.	2,905	$373,292
6	GILD	Gilead Sciences, Inc. This page	2,765	$349,330

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$349,330	2,765	—	Shares	Sole	2026-07-23
No filing history on record for this holder in this stock.

Pekao Towarzystwo Funduszy Inwestycyjnych S.A.

Position in GILD

Position in Drug Manufacturers - General

All Filings in GILD